Piper Sandler & Co’s Orthofix Medical OFIX Stock Holding History

Piper Sandler & Co’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-29,500	Closed	-$996K	–	59
2015 Q3	$996K	Sell	29,500 -5,500	-16%	-$196K	1.06%	10
2015 Q2	$1.16M	Sell	35,000 -1,000	-3%	-$34.4K	0.69%	14
2015 Q1	$1.29M	Buy	36,000 +14,000	+64%	+$440K	0.54%	19
2014 Q4	$661K	Buy	22,000 +15,500	+238%	+$454K	0.32%	22
2014 Q3	$201K	Buy	+6,500	New	+$216K	0.1%	83

Other funds holding OFIX

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Piper Sandler & Co's OFIX Position: Q4 2015 in Review

Piper Sandler & Co sold out of Orthofix Medical (OFIX) in Q4 2015, closing a stake of 29,500 shares — an estimated $996K sold.

Piper Sandler & Co first reported a position in OFIX in Q3 2014 and held it in 5 quarters. The position peaked at $1.29M in Q1 2015. 115 funds tracked by Wall St. Rank hold OFIX as of Q4 2015.

Piper Sandler & Co reported no remaining Orthofix Medical position as of Q4 2015 after selling out during the quarter.
Piper Sandler & Co sold 29,500 Orthofix Medical shares in Q4 2015, an estimated $996K.
Piper Sandler & Co first reported a position in Orthofix Medical in Q3 2014 and held it in 5 quarters.
Piper Sandler & Co's Orthofix Medical position peaked at $1.29M in Q1 2015.
115 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2015.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.